Shire: Vyvanse grows up - Pharmaceutical Business Review

Shire: Vyvanse grows up
Pharmaceutical Business Review - 11 hours ago
It is positioned as the successor to Shire's market leading ADHD drug, Adderall XR, which faces generic incursion from 2009. Although Vyvanse's capacity to …
UPDATE 1-Shire ADHD drug approved for US adults, shares jump Reuters
ADRs in Focus: Shire rises on expanded Vyvanse approval Forbes
Shire Gets FDA approval of Vyvanse for adult use Basingstoke Business News (press release)
International Herald Tribune - Reuters
all 58 news articles

April 25th, 2008
Adderall

Search Myomancy for news and information about ADHD, Dyslexia and Autism including diagnosis techniques, treatments and the science behind them.

A comprehensive list of every type of treatment available for ADHD, Autism and Dyslexia reviewed and rated by people who have tried them is available on the Myomancy Treatment Database. It covers mainstream treatments focusing on Reading as well as those less recognised using Biofeedback, Dietry and Rhythm. There are also treatments that deal with specific issues such as Audiotory, Visual, Balance, Coordination, Memory. Some treatments are provided as special centers whilst others are available via Books, CDs, DVDs or Software.

Read the latest on ADHD, Dyslexia and Autism from Myomancy via RSS 2.0 or use FeedBurner:

Myomancy ADHD, Dyslexia and Autism